\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\\.\ \(1\)\
\-\ surgical\\ resection\\ of\\ lesion\\ for\\ seizure\\ control\\ and\\ prevention\\ of\\ symptomatic\\ hemorrhage\\.\ \(0\)\
\-\ complex\\ lesion\\ with\\ cystic\\ and\\ solid\\ components\\ in\\ the\\ left\\ frontal\\ lobe\\.\\ \\ complex\\ pattern\\ of\\ high\\ and\\ low\\ signal\\ intensity\\ suggest\\ either\\ melanin\\ or\\ blood\\ products\\ within\\ the\\ lesion\\.\\ \\ little\\ or\\ no\\ mass\\ effect\\ nor\\ edema\\ suggest\\ a\\ long\\ standing\\ process\\.\\ \\ no\\ large\\ vascular\\ structures\\ are\\ present\\ on\\ mra\\.\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\ \\(\\"hemangioma\\"\\)\ \(0\)\
\-\ vascular\\ malformation\\ \\-\\ avm\ \(0\)\
\-\ neoplasm\\ \\-\\ astrocytoma\ \(1\)\
\-\ neoplasm\\ \\-\\ glioblastoma\ \(0\)\
\-\ metastatic\\ lesion\\ \\(e\\.g\\.\\ colon\\ cancer\\)\ \(0\)\
\-\ hemorrhagic\\ metastatic\\ lesion\ \(0\)\
\-\ primary\\ or\\ metastatic\\ melanoma\ \(0\)\
\-\ 14\\ y\\.o\\.\\ girl\\ with\\ first\\ seizure\\ 3\\ months\\ prior\\ to\\ admission\\.\\ \\ she\\ was\\ treated\\ medically\\ with\\ limited\\ success\\.\\ \\ mri\\ requested\\ for\\ further\\ evaluation\\.\ \(0\)\
\-\ patient\\ developed\\ mild\\ right\\ upper\\ extremity\\ weakness\\ after\\ surgery\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lesion\\:\\ 0\\.29698480265712096\ \(0\)\
\-\ seizure\\:\\ 0\\.2061893978684205\ \(0\)\
\-\ metastatic\\:\\ 0\\.20384699623093025\ \(0\)\
\-\ suggest\\:\\ 0\\.2012861560885842\ \(0\)\
\-\ malformation\\:\\ 0\\.19110792421852654\ \(0\)\
\-\ complex\\:\\ 0\\.19091529463666487\ \(0\)\
\-\ neoplasm\\:\\ 0\\.1691510208855982\ \(0\)\
\-\ vascular\\:\\ 0\\.16358423532627522\ \(0\)\
\-\ melanin\\:\\ 0\\.1611062076856623\ \(0\)\
\-\ prevention\\:\\ 0\\.15165155636560632\ \(0\)\
\-\ medically\\:\\ 0\\.14416198316799905\ \(0\)\
\-\ success\\:\\ 0\\.13418142359230242\ \(0\)\
\-\ products\\:\\ 0\\.1309973501014227\ \(0\)\
\-\ requested\\:\\ 0\\.12956481231256173\ \(0\)\
\-\ or\\:\\ 0\\.12930028870501503\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.12354895028062356\ \(0\)\
\-\ mra\\:\\ 0\\.12252266724845408\ \(0\)\
\-\ little\\:\\ 0\\.12186446688525102\ \(0\)\
\-\ nor\\:\\ 0\\.12060504454951812\ \(0\)\
\-\ melanoma\\:\\ 0\\.11569750683641192\ \(0\)\
\-\ standing\\:\\ 0\\.11521484364503502\ \(0\)\
\-\ components\\:\\ 0\\.11252452859469393\ \(0\)\
\-\ avm\\:\\ 0\\.10957171496144907\ \(0\)\
\-\ cavernous\\:\\ 0\\.10746823845633428\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.10746823845633428\ \(0\)\
\-\ control\\:\\ 0\\.10585869113217818\ \(0\)\
\-\ hemangioma\\:\\ 0\\.10421592593293331\ \(0\)\
\-\ admission\\:\\ 0\\.10336962601993657\ \(0\)\
\-\ either\\:\\ 0\\.10242223191180395\ \(0\)\
\-\ limited\\:\\ 0\\.09888587082486398\ \(0\)\
\-\ symptomatic\\:\\ 0\\.09526628969489583\ \(0\)\
\-\ solid\\:\\ 0\\.09498237781205224\ \(0\)\
\-\ colon\\:\\ 0\\.09433400280516323\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.09352784614813527\ \(0\)\
\-\ structures\\:\\ 0\\.09309258208650881\ \(0\)\
\-\ process\\:\\ 0\\.09292088988993573\ \(0\)\
\-\ pattern\\:\\ 0\\.09249750514259208\ \(0\)\
\-\ 14\\:\\ 0\\.09249750514259208\ \(0\)\
\-\ developed\\:\\ 0\\.09191829882397914\ \(0\)\
\-\ weakness\\:\\ 0\\.09041984611423123\ \(0\)\
\-\ extremity\\:\\ 0\\.08923353352446979\ \(0\)\
\-\ intensity\\:\\ 0\\.08797207872104293\ \(0\)\
\-\ effect\\:\\ 0\\.0869091657203468\ \(0\)\
\-\ girl\\:\\ 0\\.0869091657203468\ \(0\)\
\-\ cerebral\\:\\ 0\\.08583406372506323\ \(0\)\
\-\ contributory\\:\\ 0\\.08469227927117379\ \(0\)\
\-\ first\\:\\ 0\\.08360753335104748\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.08294933298784442\ \(0\)\
\-\ cancer\\:\\ 0\\.08252135953901955\ \(0\)\
\-\ long\\:\\ 0\\.08215367808974541\ \(0\)\
\-\ further\\:\\ 0\\.08069345379972066\ \(0\)\
\-\ no\\:\\ 0\\.08057705239573687\ \(0\)\
\-\ frontal\\:\\ 0\\.07974071553485236\ \(0\)\
\-\ resection\\:\\ 0\\.07941689132881008\ \(0\)\
\-\ treated\\:\\ 0\\.0771515424462268\ \(0\)\
\-\ and\\:\\ 0\\.07680278592390717\ \(0\)\
\-\ primary\\:\\ 0\\.07618070150596498\ \(0\)\
\-\ evaluation\\:\\ 0\\.07555677494554804\ \(0\)\
\-\ for\\:\\ 0\\.07510190880131619\ \(0\)\
\-\ cystic\\:\\ 0\\.07461641379654485\ \(0\)\
\-\ edema\\:\\ 0\\.07389238175951454\ \(0\)\
\-\ she\\:\\ 0\\.07375042733415994\ \(0\)\
\-\ with\\:\\ 0\\.072779272654387\ \(0\)\
\-\ of\\:\\ 0\\.07273581302343748\ \(0\)\
\-\ months\\:\\ 0\\.07211562835065215\ \(0\)\
\-\ blood\\:\\ 0\\.07195220433082339\ \(0\)\
\-\ lobe\\:\\ 0\\.07159694221304565\ \(0\)\
\-\ low\\:\\ 0\\.0710903548213652\ \(0\)\
\-\ high\\:\\ 0\\.07041254535323811\ \(0\)\
\-\ signal\\:\\ 0\\.0702313013270794\ \(0\)\
\-\ mild\\:\\ 0\\.0702313013270794\ \(0\)\
\-\ prior\\:\\ 0\\.06931823474812489\ \(0\)\
\-\ surgery\\:\\ 0\\.06661000508315626\ \(0\)\
\-\ upper\\:\\ 0\\.06620638929109435\ \(0\)\
\-\ mri\\:\\ 0\\.0635955663638549\ \(0\)\
\-\ present\\:\\ 0\\.06357341546977593\ \(0\)\
\-\ large\\:\\ 0\\.062076438783662535\ \(0\)\
\-\ surgical\\:\\ 0\\.06021593826991973\ \(0\)\
\-\ after\\:\\ 0\\.06010242433680947\ \(0\)\
\-\ non\\:\\ 0\\.0587846112710892\ \(0\)\
\-\ within\\:\\ 0\\.057061199558532345\ \(0\)\
\-\ the\\:\\ 0\\.04944220241427751\ \(0\)\
\-\ mass\\:\\ 0\\.04732373917627694\ \(0\)\
\-\ are\\:\\ 0\\.04701167993200824\ \(0\)\
\-\ was\\:\\ 0\\.04317786458857701\ \(0\)\
\-\ left\\:\\ 0\\.04226253343431339\ \(0\)\
\-\ right\\:\\ 0\\.04107558669732411\ \(0\)\
\-\ patient\\:\\ 0\\.040296105660434206\ \(0\)\
\-\ on\\:\\ 0\\.03741774975274868\ \(0\)\
\-\ to\\:\\ 0\\.030972954623267074\ \(0\)\
\-\ in\\:\\ 0\\.030820505804758546\ \(0\)\
